Neurophth is a biotechnology company based in San Diego, CA, specializing in the development of innovative therapies for optic nerve disorders. With a focus on gene therapy and advanced research and development platforms, Neurophth aims to address conditions such as Leber's Hereditary Optic Neuropathy, Autosomal Dominant Optic Atrophy, Optic Nerve Injury, and Vascular Retinopathy.
Driven by a dedicated management team and a commitment to employee development, Neurophth offers a stimulating work environment with competitive compensation and benefits. As a leader in the field, the company actively seeks partnerships and collaborations to further advance its groundbreaking therapies and make a positive impact on patients' lives.
Generated from the website